Kennondale Capital Management LLC

Position in BHVN — Biohaven Ltd.

CIK 2055199 RICHMOND, VA

Position in BHVN

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$784,071

+$338,289 QoQ

Shares Held

52,693

0.0% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

0.52%

of 13F equity value

Holder Rank

#122

of 294 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Kennondale Capital Management LLC holds $3,256,678 across 3 Biotechnology names. BHVN ranks #3 (24.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IOVA	Iovance Biotherapeutics, Inc.	318,188	$1,323,662
2	IKT	Inhibikase Therapeutics, Inc.	565,983	$1,148,945
3	BHVN	Biohaven Ltd. This page	52,693	$784,071

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$784,071	52,693	0.0%	Shares	Sole	2026-08-11
2026-03-31	$445,782	52,693	0.0%	Shares	Sole	2026-05-12
2025-12-31	$594,903	52,693	—	Shares	Sole	2026-02-13
No filing history on record for this holder in this stock.